Champlain Investment Partners LLC Has $241.94 Million Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Champlain Investment Partners LLC reduced its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 24.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 3,644,250 shares of the company’s stock after selling 1,200,472 shares during the quarter. Ryan Specialty comprises about 1.5% of Champlain Investment Partners LLC’s portfolio, making the stock its 14th largest holding. Champlain Investment Partners LLC’s holdings in Ryan Specialty were worth $241,942,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in RYAN. Hollencrest Capital Management bought a new stake in shares of Ryan Specialty during the 3rd quarter worth $25,000. Assetmark Inc. acquired a new stake in shares of Ryan Specialty in the 3rd quarter valued at approximately $34,000. GAMMA Investing LLC grew its holdings in shares of Ryan Specialty by 96.4% during the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after purchasing an additional 297 shares during the last quarter. Crewe Advisors LLC acquired a new position in Ryan Specialty during the 2nd quarter worth approximately $39,000. Finally, Rothschild Investment LLC bought a new position in Ryan Specialty in the 2nd quarter valued at approximately $87,000. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

RYAN has been the topic of a number of research reports. JPMorgan Chase & Co. boosted their target price on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research note on Friday, August 2nd. Barclays upped their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday. The Goldman Sachs Group lifted their price target on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. Wells Fargo & Company upped their price objective on Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. Finally, UBS Group lifted their target price on shares of Ryan Specialty from $67.00 to $76.00 and gave the stock a “buy” rating in a research report on Tuesday, August 13th. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Ryan Specialty currently has an average rating of “Hold” and an average price target of $71.67.

Ryan Specialty Price Performance

RYAN stock opened at $73.52 on Friday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company’s 50-day moving average is $69.06 and its 200-day moving average is $62.51. The stock has a market capitalization of $19.25 billion, a PE ratio of 95.48, a price-to-earnings-growth ratio of 1.63 and a beta of 0.62. Ryan Specialty Holdings, Inc. has a 1 year low of $41.49 and a 1 year high of $74.53.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. During the same period last year, the business earned $0.32 EPS. Ryan Specialty’s quarterly revenue was up 20.5% compared to the same quarter last year. Equities research analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th will be paid a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a yield of 0.60%. The ex-dividend date is Tuesday, November 12th. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.

Insiders Place Their Bets

In other news, Director Nicholas Dominic Cortezi sold 5,375 shares of the firm’s stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $64.73, for a total transaction of $347,923.75. Following the completion of the sale, the director now owns 2,685 shares in the company, valued at $173,800.05. This trade represents a 66.69 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Mark Stephen Katz sold 14,790 shares of Ryan Specialty stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the completion of the sale, the executive vice president now directly owns 12,386 shares in the company, valued at $884,236.54. This trade represents a 54.42 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 22,490 shares of company stock valued at $1,553,977 in the last three months. 11.10% of the stock is currently owned by insiders.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.